Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuro - endocrinology letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 23803867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response trajectories in "real-world" naturalistically treated schizophrenia patients.

  2012cited by this paper
• Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.

  2012cited by this paper
• A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.

  2012cited by this paper
• Declarative memory deficits and schizophrenia: problems and prospects.

  2011cited by this paper
• Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat

  2011cited by this paper
• Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up

  2011cited by this paper
• Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress.

  2011cited by this paper
• The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals.

  2011cited by this paper
• Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.

  2011cited by this paper
• Significance of SGK1 in the regulation of neuronal function

  2010cited by this paper
• The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine.

  2010influential reference
• Insulin Reveals Akt Signaling as a Novel Regulator of Norepinephrine Transporter Trafficking and Norepinephrine Homeostasis

  2010cited by this paper
• Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.

  2010influential reference
• GENETIC RISK AND OUTCOME OF PSYCHOSIS (GROUP), A MULTI SITE LONGITUDINAL COHORT STUDY: OBJECTIVES, RECRUITMENT AND ASSESSMENT METHODS AND CHARACTERISTICS OF INCLUDED PARTICIPANTS

  2009cited by this paper
• Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells.

  2008cited by this paper
• Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.

  2007cited by this paper
• Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia.

  2006influential reference
• Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.

  2006cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

  2005cited by this paper
• Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.

  2005cited by this paper
• Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study

  2005cited by this paper
• Effects of antipsychotics on fat deposition and changes in leptin and insulin levels

  2004cited by this paper
• Clozapine-induced weight gain predicts improvement in psychopathology.

  2003cited by this paper
• Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia.

  2003cited by this paper
• Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

  2003cited by this paper
• Olanzapine induces insulin resistance: results from a prospective study.

  2003cited by this paper
• Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls.

  2003cited by this paper
• Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential Association

  2002cited by this paper
• Peptide derived from insulin with regulatory activity of dopamine transporter.

  2001cited by this paper
• Cognitive effects of insulin in the central nervous system.

  2001cited by this paper
• Role of insulin and insulin receptor in learning and memory.

  2001cited by this paper
• Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

  2000cited by this paper
• Prevalence and correlates of diabetes in national schizophrenia samples.

  2000cited by this paper
• Intracerebroventricular Administration of Bromocriptine Ameliorates the Insulin-Resistant/Glucose-Intolerant State in Hamsters

  1999cited by this paper
• Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism.

  1999cited by this paper
• A PET Study of 5-HT2 and D2 Dopamine Receptor Occupancy Induced by Olanzapine in Healthy Subjects

  1997cited by this paper
• Diabetes decreases limbic extracellular dopamine in rats.

  1996cited by this paper
• Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats

  1996cited by this paper
• The evaluation of insulin as a metabolic signal influencing behavior via the brain.

  1996cited by this paper
• Brain Glucose Metabolism Is Controlled by Amplification and Desensitization of the Neuronal Insulin Receptor a

  1996cited by this paper
• Effects of posttraining administration of glucose on retention of a habituation response in mice: participation of a central cholinergic mechanism.

  1996cited by this paper
• Schizophrenia is a diabetic brain state: an elucidation of impaired neurometabolism.

  1994cited by this paper
• Insulin gene expression and insulin synthesis in mammalian neuronal cells.

  1994cited by this paper
• Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra.

  1994cited by this paper
• Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus.

  1993cited by this paper
• The effect of insulin on norepinephrine uptake by PC12 cells.

  1993cited by this paper
• Distribution of insulin receptor-like immunoreactivity in the rat forebrain.

  1989cited by this paper
• Insulin synthesis by isolated rabbit neurons.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Insulin: its relationship to the central nervous system and to the control of food intake and body weight.

  1985influential reference
• Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay.

  1978cited by this paper

• Olanzapine-Induced Weight Gain and Glycolipid Metabolism Aberrations in First-Episode and Antipsychotic-Naïve Schizophrenia Patients: A Longitudinal Study

  2024cites this paper
• Intrinsic Therapeutic Link between Recuperative Cerebellar Con-Nectivity and Psychiatry Symptom in Schizophrenia Patients with Comorbidity of Metabolic Syndrome

  2023cites this paper
• Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review.

  2023cites this paper
• Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study

  2021cites this paper
• The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment

  2018influential citation
• The prevalence of diabetes mellitus and abnormal glucose metabolism in the inpatient psychiatric setting: A systematic review and meta-analysis.

  2017cites this paper
• Eye growth and myopia development: Unifying theory and Matlab model

  2016cites this paper